{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T16:36:51Z","timestamp":1779122211637,"version":"3.51.4"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T00:00:00Z","timestamp":1663891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T00:00:00Z","timestamp":1663891200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"HHS \u00a6 NIH \u00a6 National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01\u2010HL162308"],"award-info":[{"award-number":["R01\u2010HL162308"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"HHS \u00a6 NIH \u00a6 National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL157489"],"award-info":[{"award-number":["R01HL157489"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"HHS \u00a6 NIH \u00a6 National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R43\u2010AI162329"],"award-info":[{"award-number":["R43\u2010AI162329"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Mol Med"],"published-print":{"date-parts":[[2022,11,8]]},"DOI":"10.15252\/emmm.202216109","type":"journal-article","created":{"date-parts":[[2022,9,12]],"date-time":"2022-09-12T10:54:21Z","timestamp":1662980061000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["An ACE2 decoy can be administered by inhalation and potently targets omicron variants of SARS\u2010CoV\u20102"],"prefix":"10.1038","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3037-9173","authenticated-orcid":false,"given":"Lianghui","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7221-293X","authenticated-orcid":false,"given":"Krishna K","family":"Narayanan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6322-1260","authenticated-orcid":false,"given":"Laura","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kui K","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Savanna S","family":"Skeeters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8541-7432","authenticated-orcid":false,"given":"Christine A","family":"Devlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron","family":"Aguhob","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristie","family":"Shirley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3938-0445","authenticated-orcid":false,"given":"Lijun","family":"Rong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2787-9292","authenticated-orcid":false,"given":"Jalees","family":"Rehman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8205-7128","authenticated-orcid":false,"given":"Asrar B","family":"Malik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0028-490X","authenticated-orcid":false,"given":"Erik","family":"Procko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,9,23]]},"reference":[{"key":"BFEMMM202216109_CR1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3389\/fddsv.2021.789710","volume":"1","author":"U Bastolla","year":"2022","unstructured":"Bastolla U, Chambers P, Abia D, Garcia\u2010Bermejo M\u2010L, Fresno M (2022) Is Covid\u201019 severity associated with ACE2 degradation? Front Drug Discov 1: 5","journal-title":"Front Drug Discov"},{"key":"BFEMMM202216109_CR2","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1126\/science.abd0831","volume":"369","author":"A Baum","year":"2020","unstructured":"Baum A, Fulton BO, Wloga E, Copin R, Pascal KE, Russo V, Giordano S, Lanza K, Negron N, Ni M et\u2009al (2020) Antibody cocktail to SARS\u2010CoV\u20102 spike protein prevents rapid mutational escape seen with individual antibodies. Science 369: 1014\u20131018","journal-title":"Science"},{"key":"BFEMMM202216109_CR3","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41586-021-04385-3","volume":"602","author":"Y Cao","year":"2022","unstructured":"Cao Y, Wang J, Jian F, Xiao T, Song W, Yisimayi A, Huang W, Li Q, Wang P, An R et\u2009al (2022a) Omicron escapes the majority of existing SARS\u2010CoV\u20102 neutralizing antibodies. Nature 602: 657\u2013663","journal-title":"Nature"},{"key":"BFEMMM202216109_CR4","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/s41586-022-04980-y","volume":"608","author":"Y Cao","year":"2022","unstructured":"Cao Y, Yisimayi A, Jian F, Song W, Xiao T, Wang L, Du S, Wang J, Li Q, Chen X et\u2009al (2022b) BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by omicron infection. Nature 608: 593\u2013602","journal-title":"Nature"},{"key":"BFEMMM202216109_CR5","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/s41586-021-04387-1","volume":"602","author":"S Cele","year":"2021","unstructured":"Cele S, Jackson L, Khoury DS, Khan K, Moyo\u2010Gwete T, Tegally H, San JE, Cromer D, Scheepers C, Amoako DG et\u2009al (2021) Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization. Nature 602: 654","journal-title":"Nature"},{"key":"BFEMMM202216109_CR6","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1126\/science.abc0870","volume":"369","author":"KK Chan","year":"2020","unstructured":"Chan KK, Dorosky D, Sharma P, Abbasi SA, Dye JM, Kranz DM, Herbert AS, Procko E (2020) Engineering human ACE2 to optimize binding to the spike protein of SARS coronavirus 2. Science 369: 1261\u20131265","journal-title":"Science"},{"key":"BFEMMM202216109_CR7","doi-asserted-by":"crossref","first-page":"eabf1738","DOI":"10.1126\/sciadv.abf1738","volume":"7","author":"KK Chan","year":"2021","unstructured":"Chan KK, Tan TJC, Narayanan KK, Procko E (2021) An engineered decoy receptor for SARS\u2010CoV\u20102 broadly binds protein S sequence variants. Sci Adv 7: eabf1738","journal-title":"Sci Adv"},{"key":"BFEMMM202216109_CR8","doi-asserted-by":"crossref","unstructured":"Chen Y, Sun L, Ullah I, Beaudoin\u2010Bussi\u00e8res G, Priya S, Hederman AP, Tolbert WD, Sherburn R, Nguyen DN, Marchitto L et\u2009al (2021) Engineered ACE2\u2010fc counters murine lethal SARS\u2010CoV\u20102 infection through direct 1 neutralization and fc\u2010effector activities 2. bioRxivhttps:\/\/doi.org\/10.1101\/2021.11.24.469776 [PREPRINT]","DOI":"10.1101\/2021.11.24.469776"},{"key":"BFEMMM202216109_CR9","doi-asserted-by":"crossref","unstructured":"Cohen\u2010Dvashi H, Weinstein J, Katz M, Eilon M, Mor Y, Shimon A, Strobelt R, Shemesh M, Fleishman SJ, Diskin R (2020) Coronacept \u2013 a potent immunoadhesin against SARS\u2010CoV\u20102. bioRxivhttps:\/\/doi.org\/10.1101\/2020.08.12.247940 [PREPIRNT]","DOI":"10.1101\/2020.08.12.247940"},{"key":"BFEMMM202216109_CR10","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/pro.2389","volume":"23","author":"P Conway","year":"2014","unstructured":"Conway P, Tyka MD, DiMaio F, Konerding DE, Baker D (2014) Relaxation of backbone bond geometry improves protein energy landscape modeling. Protein Sci 23: 47\u201355","journal-title":"Protein Sci"},{"key":"BFEMMM202216109_CR11","doi-asserted-by":"crossref","first-page":"3949","DOI":"10.1016\/j.cell.2021.06.002","volume":"184","author":"R Copin","year":"2021","unstructured":"Copin R, Baum A, Wloga E, Pascal KE, Giordano S, Fulton BO, Zhou A, Negron N, Lanza K, Chan N et\u2009al (2021) The monoclonal antibody combination REGEN\u2010COV protects against SARS\u2010CoV\u20102 mutational escape in preclinical and human studies. Cell 184: 3949\u20133961","journal-title":"Cell"},{"key":"BFEMMM202216109_CR12","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ijid.2021.11.028","volume":"115","author":"M Fagyas","year":"2022","unstructured":"Fagyas M, Fejes Z, S\u00fct\u0151 R, Nagy Z, Sz\u00e9kely B, P\u00f3csi M, Iv\u00e1dy G, B\u00edr\u00f3 E, Bek\u0151 G, Nagy A et\u2009al (2022) Circulating ACE2 activity predicts mortality and disease severity in hospitalized COVID\u201019 patients. Int J Infect Dis 115: 8\u201316","journal-title":"Int J Infect Dis"},{"key":"BFEMMM202216109_CR13","volume":"2","author":"MR Filbin","year":"2021","unstructured":"Filbin MR, Mehta A, Schneider AM, Kays KR, Guess JR, Gentili M, Fenyves BG, Charland NC, Gonye ALK, Gushterova I et\u2009al (2021) Longitudinal proteomic analysis of severe COVID\u201019 reveals survival\u2010associated signatures, tissue\u2010specific cell death, and cell\u2010cell interactions. Cell Rep Med 2: 100287","journal-title":"Cell Rep Med"},{"key":"BFEMMM202216109_CR14","doi-asserted-by":"crossref","first-page":"28046","DOI":"10.1073\/pnas.2016093117","volume":"117","author":"A Glasgow","year":"2020","unstructured":"Glasgow A, Glasgow J, Limonta D, Solomon P, Lui I, Zhang Y, Nix MA, Rettko NJ, Zha S, Yamin R et\u2009al (2020) Engineered ACE2 receptor traps potently neutralize SARS\u2010CoV\u20102. Proc Natl Acad Sci U S A 117: 28046\u201328055","journal-title":"Proc Natl Acad Sci U S A"},{"key":"BFEMMM202216109_CR15","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1001\/jama.2021.0202","volume":"325","author":"RL Gottlieb","year":"2021","unstructured":"Gottlieb RL, Nirula A, Chen P, Boscia J, Heller B, Morris J, Huhn G, Cardona J, Mocherla B, Stosor V et\u2009al (2021) Effect of bamlanivimab as monotherapy or in combination with etesevimab on viral load in patients with mild to moderate COVID\u201019: a randomized clinical trial. JAMA 325: 632\u2013644","journal-title":"JAMA"},{"key":"BFEMMM202216109_CR16","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1056\/NEJMoa2107934","volume":"385","author":"A Gupta","year":"2021","unstructured":"Gupta A, Gonzalez\u2010Rojas Y, Juarez E, Crespo Casal M, Moya J, Falci DR, Sarkis E, Solis J, Zheng H, Scott N et\u2009al (2021) Early treatment for Covid\u201019 with SARS\u2010CoV\u20102 neutralizing antibody Sotrovimab. N Engl J Med 385: 1941\u20131950","journal-title":"N Engl J Med"},{"key":"BFEMMM202216109_CR17","doi-asserted-by":"crossref","first-page":"7809","DOI":"10.1073\/pnas.0711241105","volume":"105","author":"S Haga","year":"2008","unstructured":"Haga S, Yamamoto N, Nakai\u2010Murakami C, Osawa Y, Tokunaga K, Sata T, Yamamoto N, Sasazuki T, Ishizaka Y (2008) Modulation of TNF\u2010\u03b1\u2010converting enzyme by the spike protein of SARS\u2010CoV and ACE2 induces TNF\u2010\u03b1 production and facilitates viral entry. Proc Natl Acad Sci U S A 105: 7809\u20137814","journal-title":"Proc Natl Acad Sci U S A"},{"key":"BFEMMM202216109_CR18","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/s41586-022-04441-6","volume":"603","author":"PJ Halfmann","year":"2022","unstructured":"Halfmann PJ, Iida S, Iwatsuki\u2010Horimoto K, Maemura T, Kiso M, Scheaffer SM, Darling TL, Joshi A, Loeber S, Singh G et\u2009al (2022) SARS\u2010CoV\u20102 omicron virus causes attenuated disease in mice and hamsters. Nature 603: 687\u2013692","journal-title":"Nature"},{"key":"BFEMMM202216109_CR19","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/path.1570","volume":"203","author":"I Hamming","year":"2004","unstructured":"Hamming I, Timens W, Bulthuis MLC, Lely AT, Navis GJ, van Goor H (2004) Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol 203: 631\u2013637","journal-title":"J Pathol"},{"key":"BFEMMM202216109_CR20","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1126\/science.abd0827","volume":"369","author":"J Hansen","year":"2020","unstructured":"Hansen J, Baum A, Pascal KE, Russo V, Giordano S, Wloga E, Fulton BO, Yan Y, Koon K, Patel K et\u2009al (2020) Studies in humanized mice and convalescent humans yield a SARS\u2010CoV\u20102 antibody cocktail. Science 369: 1010\u20131014","journal-title":"Science"},{"key":"BFEMMM202216109_CR21","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1128\/JVI.02202-13","volume":"88","author":"A Heurich","year":"2014","unstructured":"Heurich A, Hofmann\u2010Winkler H, Gierer S, Liepold T, Jahn O, P\u00f6hlmann S (2014) TMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike protein. J Virol 88: 1293\u20131307","journal-title":"J Virol"},{"key":"BFEMMM202216109_CR22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-021-24013-y","volume":"12","author":"Y Higuchi","year":"2021","unstructured":"Higuchi Y, Suzuki T, Arimori T, Ikemura N, Mihara E, Kirita Y, Ohgitani E, Mazda O, Motooka D, Nakamura S et\u2009al (2021) Engineered ACE2 receptor therapy overcomes mutational escape of SARS\u2010CoV\u20102. Nat Commun 12: 1\u201313","journal-title":"Nat Commun"},{"key":"BFEMMM202216109_CR23","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.3389\/fcimb.2021.781429","volume":"11","author":"SM Hirabara","year":"2022","unstructured":"Hirabara SM, Serdan TDA, Gorjao R, Masi LN, Pithon\u2010Curi TC, Covas DT, Curi R, Durigon EL (2022) SARS\u2010COV\u20102 variants: differences and potential of immune evasion. Front Cell Infect Microbiol 11: 1401","journal-title":"Front Cell Infect Microbiol"},{"key":"BFEMMM202216109_CR24","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.bbrc.2004.05.114","volume":"319","author":"H Hofmann","year":"2004","unstructured":"Hofmann H, Geier M, Marzi A, Krumbiegel M, Peipp M, Fey GH, Gramberg T, P\u00f6hlmann S (2004) Susceptibility to SARS coronavirus S protein\u2010driven infection correlates with expression of angiotensin converting enzyme 2 and infection can be blocked by soluble receptor. Biochem Biophys Res Commun 319: 1216\u20131221","journal-title":"Biochem Biophys Res Commun"},{"key":"BFEMMM202216109_CR25","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/s41401-020-0485-4","volume":"41","author":"Y Huang","year":"2020","unstructured":"Huang Y, Yang C, Feng XX, Xu W, Wen LS (2020) Structural and functional properties of SARS\u2010CoV\u20102 spike protein: potential antivirus drug development for COVID\u201019. Acta Pharmacol Sin 41: 1141\u20131149","journal-title":"Acta Pharmacol Sin"},{"key":"BFEMMM202216109_CR26","doi-asserted-by":"crossref","unstructured":"Ikemura N, Taminishi S, Inaba T, Arimori T, Motooka D, Katoh K, Kirita Y, Higuchi Y, Li S, Suzuki T et\u2009al (2022) Engineered ACE2 counteracts vaccine\u2010evading SARS\u2010CoV\u20102 omicron variant. bioRxivhttps:\/\/doi.org\/10.1101\/2021.12.22.473804 [PREPRINT]","DOI":"10.1101\/2021.12.22.473804"},{"key":"BFEMMM202216109_CR27","doi-asserted-by":"crossref","unstructured":"Iketani S, Liu L, Guo Y, Liu L, Huang Y, Wang M, Luo Y, Yu J, Yin MT, Sobieszczyk ME et\u2009al (2022) Antibody evasion properties of SARS\u2010CoV\u20102 omicron sublineages. bioRxivhttps:\/\/doi.org\/10.1101\/2022.02.07.479306 [PREPRINT]","DOI":"10.1101\/2022.02.07.479306"},{"key":"BFEMMM202216109_CR28","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nature03712","volume":"436","author":"Y Imai","year":"2005","unstructured":"Imai Y, Kuba K, Rao S, Huan Y, Guo F, Guan B, Yang P, Sarao R, Wada T, Leong\u2010Poi H et\u2009al (2005) Angiotensin\u2010converting enzyme 2 protects from severe acute lung failure. Nature 436: 112\u2013116","journal-title":"Nature"},{"key":"BFEMMM202216109_CR29","doi-asserted-by":"crossref","unstructured":"Iwanaga N, Cooper L, Rong L, Beddingfield B, Crabtree J, Tripp RA, Qin X, Kolls JK (2020) Novel ACE2\u2010IgG1 fusions with improved in\u2009vitro and in\u2009vivo activity against SARS\u2010CoV2. bioRxivhttps:\/\/doi.org\/10.1101\/2020.06.15.152157 [PREPRINT]","DOI":"10.1101\/2020.06.15.152157"},{"key":"BFEMMM202216109_CR30","volume":"8","author":"B Jensen","year":"2021","unstructured":"Jensen B, Luebke N, Feldt T, Keitel V, Brandenburger T, Kindgen\u2010Milles D, Lutterbeck M, Freise NF, Schoeler D, Haas R et\u2009al (2021) Emergence of the E484K mutation in SARS\u2010COV\u20102\u2010infected immunocompromised patients treated with bamlanivimab in Germany. Lancet Reg Health Eur 8: 100164","journal-title":"Lancet Reg Health Eur"},{"key":"BFEMMM202216109_CR31","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1002\/prot.26140","volume":"89","author":"W Jing","year":"2021","unstructured":"Jing W, Procko E (2021) ACE2\u2010based decoy receptors for SARS coronavirus 2. Proteins 89: 1065\u20131078","journal-title":"Proteins"},{"key":"BFEMMM202216109_CR32","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1126\/scitranslmed.abf1906","volume":"13","author":"BE Jones","year":"2021","unstructured":"Jones BE, Brown\u2010Augsburger PL, Corbett KS, Westendorf K, Davies J, Cujec TP, Wiethoff CM, Blackbourne JL, Heinz BA, Foster D et\u2009al (2021) The neutralizing antibody, LY\u2010CoV555, protects against SARS\u2010CoV\u20102 infection in nonhuman primates. Sci Transl Med 13: 1906","journal-title":"Sci Transl Med"},{"key":"BFEMMM202216109_CR33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0252799","volume":"16","author":"TW Kragstrup","year":"2021","unstructured":"Kragstrup TW, Singh HS, Grundberg I, Nielsen ALL, Rivellese F, Mehta A, Goldberg MB, Filbin MR, Qvist P, Bibby BM (2021) Plasma ACE2 predicts outcome of COVID\u201019 in hospitalized patients. PLoS One 16: e0252799","journal-title":"PLoS One"},{"key":"BFEMMM202216109_CR34","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nm1267","volume":"11","author":"K Kuba","year":"2005","unstructured":"Kuba K, Imai Y, Rao S, Gao H, Guo F, Guan B, Huan Y, Yang P, Zhang Y, Deng W et\u2009al (2005) A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus\u2010induced lung injury. Nat Med 11: 875\u2013879","journal-title":"Nat Med"},{"key":"BFEMMM202216109_CR35","doi-asserted-by":"crossref","first-page":"5468","DOI":"10.3389\/fimmu.2021.732690","volume":"12","author":"K Kuba","year":"2021","unstructured":"Kuba K, Yamaguchi T, Penninger JM (2021) Angiotensin\u2010converting enzyme 2 (ACE2) in the pathogenesis of ARDS in COVID\u201019. Front Immunol 12: 5468","journal-title":"Front Immunol"},{"key":"BFEMMM202216109_CR36","first-page":"1","volume":"11","author":"C Lei","year":"2020","unstructured":"Lei C, Qian K, Li T, Zhang S, Fu W, Ding M, Hu S (2020) Neutralization of SARS\u2010CoV\u20102 spike pseudotyped virus by recombinant ACE2\u2010Ig. Nat Commun 11: 1\u20135","journal-title":"Nat Commun"},{"key":"BFEMMM202216109_CR37","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/s41592-020-0848-2","volume":"17","author":"JK Leman","year":"2020","unstructured":"Leman JK, Weitzner BD, Lewis SM, Adolf\u2010Bryfogle J, Alam N, Alford RF, Aprahamian M, Baker D, Barlow KA, Barth P et\u2009al (2020) Macromolecular modeling and design in Rosetta: Recent methods and frameworks. Nat Methods 17: 665\u2013680","journal-title":"Nat Methods"},{"key":"BFEMMM202216109_CR38","first-page":"1929","volume":"9","author":"L Lin","year":"2021","unstructured":"Lin L, Liu Y, Tang X, He D (2021) The disease severity and clinical outcomes of the SARS\u2010CoV\u20102 variants of concern. Front Public Health 9: 1929","journal-title":"Front Public Health"},{"key":"BFEMMM202216109_CR39","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s11427-020-1643-8","volume":"63","author":"Y Liu","year":"2020","unstructured":"Liu Y, Yang Y, Zhang C, Huang F, Wang F, Yuan J, Wang Z, Li J, Li J, Feng C et\u2009al (2020) Clinical and biochemical indexes from 2019\u2010nCoV infected patients linked to viral loads and lung injury. Sci China Life Sci 63: 364\u2013374","journal-title":"Sci China Life Sci"},{"key":"BFEMMM202216109_CR40","doi-asserted-by":"crossref","first-page":"5908","DOI":"10.1002\/jmv.27144","volume":"93","author":"A Lundstr\u00f6m","year":"2021","unstructured":"Lundstr\u00f6m A, Ziegler L, Havervall S, Rudberg A, Meijenfeldt F, Lisman T, Mackman N, Sand\u00e9n P, Th\u00e5lin C (2021) Soluble angiotensin\u2010converting enzyme 2 is transiently elevated in COVID\u201019 and correlates with specific inflammatory and endothelial markers. J Med Virol 93: 5908\u20135916","journal-title":"J Med Virol"},{"key":"BFEMMM202216109_CR41","doi-asserted-by":"crossref","unstructured":"Lyngse FP, Kirkeby CT, Denwood M, Christiansen LE, M\u00f8lbak K, M\u00f8ller CH, Skov RL, Krause TG, Rasmussen M, Sieber RN et\u2009al (2022) Transmission of SARS\u2010CoV\u20102 omicron VOC subvariants BA.1 and BA.2: 2 evidence from Danish households. medRxivhttps:\/\/doi.org\/10.1101\/2022.01.28.22270044 [PREPRINT]","DOI":"10.1101\/2022.01.28.22270044"},{"key":"BFEMMM202216109_CR42","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1002\/jmv.27558","volume":"94","author":"S Majumdar","year":"2022","unstructured":"Majumdar S, Sarkar R (2022) Mutational and phylogenetic analyses of the two lineages of the omicron variant. J Med Virol 94: 1777\u20131779","journal-title":"J Med Virol"},{"key":"BFEMMM202216109_CR43","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.cell.2020.04.004","volume":"181","author":"V Monteil","year":"2020","unstructured":"Monteil V, Kwon H, Prado P, Hagelkr\u00fcys A, Wimmer RA, Stahl M, Leopoldi A, Garreta E, Hurtado del Pozo C, Prosper F et\u2009al (2020) Inhibition of SARS\u2010CoV\u20102 infections in engineered human tissues using clinical\u2010grade soluble human ACE2. Cell 181: 905\u2013913","journal-title":"Cell"},{"key":"BFEMMM202216109_CR44","doi-asserted-by":"crossref","first-page":"10628","DOI":"10.1128\/JVI.78.19.10628-10635.2004","volume":"78","author":"MJ Moore","year":"2004","unstructured":"Moore MJ, Dorfman T, Li W, Wong SK, Li Y, Kuhn JH, Coderre J, Vasilieva N, Han Z, Greenough TC et\u2009al (2004) Retroviruses Pseudotyped with the severe acute respiratory syndrome coronavirus spike protein efficiently infect cells expressing angiotensin\u2010converting enzyme 2. J Virol 78: 10628\u201310635","journal-title":"J Virol"},{"key":"BFEMMM202216109_CR45","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1001\/jama.2021.24939","volume":"327","author":"MP O'Brien","year":"2022","unstructured":"O'Brien MP, Forleo\u2010Neto E, Sarkar N, Isa F, Hou P, Chan KC, Musser BJ, Bar KJ, Barnabas RV, Barouch DH et\u2009al (2022) Effect of subcutaneous Casirivimab and Imdevimab antibody combination vs placebo on development of symptomatic COVID\u201019 in early asymptomatic SARS\u2010CoV\u20102 infection: a randomized clinical trial. JAMA 327: 432\u2013441","journal-title":"JAMA"},{"key":"BFEMMM202216109_CR46","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/s41586-020-2349-y","volume":"583","author":"D Pinto","year":"2020","unstructured":"Pinto D, Park YJ, Beltramello M, Walls AC, Tortorici MA, Bianchi S, Jaconi S, Culap K, Zatta F, de Marco A et\u2009al (2020) Cross\u2010neutralization of SARS\u2010CoV\u20102 by a human monoclonal SARS\u2010CoV antibody. Nature 583: 290\u2013295","journal-title":"Nature"},{"key":"BFEMMM202216109_CR47","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/s41586-021-04389-z","volume":"602","author":"D Planas","year":"2022","unstructured":"Planas D, Saunders N, Maes P, Guivel\u2010Benhassine F, Planchais C, Buchrieser J, Bolland WH, Porrot F, Staropoli I, Lemoine F et\u2009al (2022) Considerable escape of SARS\u2010CoV\u20102 omicron to antibody neutralization. Nature 602: 671\u2013675","journal-title":"Nature"},{"key":"BFEMMM202216109_CR48","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1164\/rccm.202101-0142LE","volume":"203","author":"R Reindl\u2010Schwaighofer","year":"2021","unstructured":"Reindl\u2010Schwaighofer R, H\u00f6dlmoser S, Eskandary F, Poglitsch M, Bonderman D, Strassl R, Aberle JH, Oberbauer R, Zoufaly A, Hecking M (2021) ACE2 elevation in severe COVID\u201019. Am J Respir Crit Care Med 203: 1191\u20131196","journal-title":"Am J Respir Crit Care Med"},{"key":"BFEMMM202216109_CR49","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1056\/NEJMc2120219","volume":"386","author":"R Rockett","year":"2022","unstructured":"Rockett R, Basile K, Maddocks S, Fong W, Agius JE, Johnson\u2010Mackinnon J, Arnott A, Chandra S, Gall M, Draper J et\u2009al (2022) Resistance mutations in SARS\u2010CoV\u20102 Delta variant after Sotrovimab use. N Engl J Med 386: 1477\u20131479","journal-title":"N Engl J Med"},{"key":"BFEMMM202216109_CR50","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1056\/NEJMc2119236","volume":"386","author":"A R\u00f6ssler","year":"2022","unstructured":"R\u00f6ssler A, Riepler L, Bante D, von Laer D, Kimpel J (2022) SARS\u2010CoV\u20102 omicron variant neutralization in serum from vaccinated and convalescent persons. N Engl J Med 386: 698\u2013700","journal-title":"N Engl J Med"},{"key":"BFEMMM202216109_CR51","doi-asserted-by":"crossref","first-page":"8258","DOI":"10.1073\/pnas.1432869100","volume":"100","author":"RAS Santos","year":"2003","unstructured":"Santos RAS, Simoes e Silva AC, Maric C, Silva DMR, Machado RP, de Buhr I, Heringer\u2010Walther S, Pinheiro SVB, Lopes MT, Bader M et\u2009al (2003) Angiotensin\u2010(1\u20107) is an endogenous ligand for the G protein\u2010coupled receptor mas. Proc Natl Acad Sci U S A 100: 8258\u20138263","journal-title":"Proc Natl Acad Sci U S A"},{"key":"BFEMMM202216109_CR52","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41586-020-2381-y","volume":"584","author":"R Shi","year":"2020","unstructured":"Shi R, Shan C, Duan X, Chen Z, Liu P, Song J, Song T, Bi X, Han C, Wu L et\u2009al (2020) A human neutralizing antibody targets the receptor\u2010binding site of SARS\u2010CoV\u20102. Nature 584: 120\u2013124","journal-title":"Nature"},{"key":"BFEMMM202216109_CR53","volume":"17","author":"JJ Sims","year":"2021","unstructured":"Sims JJ, Greig JA, Michalson KT, Lian S, Martino RA, Meggersee R, Turner KB, Nambiar K, Dyer C, Hinderer C et\u2009al (2021) Intranasal gene therapy to prevent infection by SARS\u2010CoV\u20102 variants. PLoS Pathog 17: e1009544","journal-title":"PLoS Pathog"},{"key":"BFEMMM202216109_CR54","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.cell.2020.08.012","volume":"182","author":"TN Starr","year":"2020","unstructured":"Starr TN, Greaney AJ, Hilton SK, Ellis D, Crawford KHD, Dingens AS, Navarro MJ, Bowen JE, Tortorici MA, Walls AC et\u2009al (2020) Deep mutational scanning of SARS\u2010CoV\u20102 receptor binding domain reveals constraints on folding and ACE2 binding. Cell 182: 1295\u20131310","journal-title":"Cell"},{"key":"BFEMMM202216109_CR55","first-page":"1","volume":"11","author":"S Tanaka","year":"2021","unstructured":"Tanaka S, Nelson G, Olson CA, Buzko O, Higashide W, Shin A, Gonzalez M, Taft J, Patel R, Buta S et\u2009al (2021) An ACE2 triple decoy that neutralizes SARS\u2010CoV\u20102 shows enhanced affinity for virus variants. Sci Rep 11: 1\u201312","journal-title":"Sci Rep"},{"key":"BFEMMM202216109_CR56","unstructured":"Tegally H, Moir M, Everatt J, Giovanetti M, Scheepers C, Wilkinson E, Subramoney K, Moyo S, Amoako DG, Baxter C et\u2009al (2022) Continued emergence and evolution of omicron in South Africa: new BA.4 and BA.5 lineages. medRxiv 10.1101\/2022.05.01.22274406 [PREPRINT]"},{"key":"BFEMMM202216109_CR57","doi-asserted-by":"crossref","first-page":"33238","DOI":"10.1074\/jbc.M002615200","volume":"275","author":"SR Tipnis","year":"2000","unstructured":"Tipnis SR, Hooper NM, Hyde R, Karran E, Christie G, Turner AJ (2000) A human homolog of angiotensin\u2010converting enzyme: cloning and functional expression as a captopril\u2010insensitive carboxypeptidase. J Biol Chem 275: 33238\u201333243","journal-title":"J Biol Chem"},{"key":"BFEMMM202216109_CR58","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1097\/CCM.0b013e3181c03009","volume":"38","author":"B Treml","year":"2010","unstructured":"Treml B, Neu N, Kleinsasser A, Gritsch C, Finsterwalder T, Geiger R, Schuster M, Janzek E, Loibner H, Penninger J et\u2009al (2010) Recombinant angiotensin\u2010converting enzyme 2 improves pulmonary blood flow and oxygenation in lipopolysaccharide\u2010induced lung injury in piglets. Crit Care Med 38: 596\u2013601","journal-title":"Crit Care Med"},{"key":"BFEMMM202216109_CR59","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/s41591-021-01678-y","volume":"28","author":"LA VanBlargan","year":"2022","unstructured":"VanBlargan LA, Errico JM, Halfmann PJ, Zost SJ, Crowe JE, Purcell LA, Kawaoka Y, Corti D, Fremont DH, Diamond MS (2022) An infectious SARS\u2010CoV\u20102 B.1.1.529 omicron virus escapes neutralization by therapeutic monoclonal antibodies. Nat Med 28: 490\u2013495","journal-title":"Nat Med"},{"key":"BFEMMM202216109_CR60","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41586-022-04411-y","volume":"603","author":"R Viana","year":"2022","unstructured":"Viana R, Moyo S, Amoako DG, Tegally H, Scheepers C, Althaus CL, Anyaneji UJ, Bester PA, Boni MF, Chand M et\u2009al (2022) Rapid epidemic expansion of the SARS\u2010CoV\u20102 omicron variant in southern Africa. Nature 603: 679\u2013686","journal-title":"Nature"},{"key":"BFEMMM202216109_CR61","doi-asserted-by":"crossref","first-page":"14838","DOI":"10.1074\/jbc.M200581200","volume":"277","author":"C Vickers","year":"2002","unstructured":"Vickers C, Hales P, Kaushik V, Dick L, Gavin J, Tang J, Godbout K, Parsons T, Baronas E, Hsieh F et\u2009al (2002) Hydrolysis of biological peptides by human angiotensin\u2010converting enzyme\u2010related carboxypeptidase. J Biol Chem 277: 14838\u201314843","journal-title":"J Biol Chem"},{"key":"BFEMMM202216109_CR62","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1002\/jmv.27516","volume":"94","author":"L Wang","year":"2022","unstructured":"Wang L, Cheng G (2022) Sequence analysis of the emerging SARS\u2010CoV\u20102 variant omicron in South Africa. J Med Virol 94: 1728\u20131733","journal-title":"J Med Virol"},{"key":"BFEMMM202216109_CR63","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2108163","volume":"385","author":"DM Weinreich","year":"2021","unstructured":"Weinreich DM, Sivapalasingam S, Norton T, Ali S, Gao H, Bhore R, Xiao J, Hooper AT, Hamilton JD, Musser BJ et\u2009al (2021) REGEN\u2010COV antibody combination and outcomes in outpatients with Covid\u201019. N Engl J Med 385: e81","journal-title":"N Engl J Med"},{"key":"BFEMMM202216109_CR64","doi-asserted-by":"crossref","unstructured":"Westendorf K, \u017dentelis S, Wang L, Foster D, Vaillancourt P, Wiggin M, Lovett E, van der Lee R, Hendle J, Pustilnik A et\u2009al (2022) LY\u2010CoV1404 (bebtelovimab) potently neutralizes SARS\u2010CoV\u20102 variants. bioRxivhttps:\/\/doi.org\/10.1101\/2021.04.30.442182 [PREPRINT]","DOI":"10.1101\/2021.04.30.442182"},{"key":"BFEMMM202216109_CR65","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1186\/s13054-020-03015-0","volume":"24","author":"Z Wu","year":"2020","unstructured":"Wu Z, Hu R, Zhang C, Ren W, Yu A, Zhou X (2020) Elevation of plasma angiotensin II level is a potential pathogenesis for the critically ill COVID\u201019 patients. Crit Care 24: 290","journal-title":"Crit Care"},{"key":"BFEMMM202216109_CR66","first-page":"1","volume":"12","author":"T Yamaguchi","year":"2021","unstructured":"Yamaguchi T, Hoshizaki M, Minato T, Nirasawa S, Asaka MN, Niiyama M, Imai M, Uda A, Chan JFW, Takahashi S et\u2009al (2021) ACE2\u2010like carboxypeptidase B38\u2010CAP protects from SARS\u2010CoV\u20102\u2010induced lung injury. Nat Commun 12: 1\u201313","journal-title":"Nat Commun"},{"key":"BFEMMM202216109_CR67","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1126\/science.abb2762","volume":"367","author":"R Yan","year":"2020","unstructured":"Yan R, Zhang Y, Li Y, Xia L, Guo Y, Zhou Q (2020) Structural basis for the recognition of SARS\u2010CoV\u20102 by full\u2010length human ACE2. Science 367: 1444\u20131448","journal-title":"Science"},{"key":"BFEMMM202216109_CR68","doi-asserted-by":"crossref","unstructured":"Yao W, Ma D, Wang H, Tang X, Du C, Li C, Lin H, Farzan M, Zhao J, Li Y et\u2009al (2021) Effect of SARS\u2010CoV\u20102 spike mutations on animal ACE2 usage and in\u2009vitro neutralization sensitivity. bioRxivhttps:\/\/doi.org\/10.1101\/2021.01.27.428353 [PREPRINT]","DOI":"10.1101\/2021.01.27.428353"},{"key":"BFEMMM202216109_CR69","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1126\/science.abn8863","volume":"375","author":"W Yin","year":"2022","unstructured":"Yin W, Xu Y, Xu P, Cao X, Wu C, Gu C, He X, Wang X, Huang S, Yuan Q et\u2009al (2022) Structures of the omicron spike trimer with ACE2 and an anti\u2010omicron antibody. Science 375: 1048\u20131053","journal-title":"Science"},{"key":"BFEMMM202216109_CR70","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/s41589-021-00965-6","volume":"18","author":"L Zhang","year":"2022","unstructured":"Zhang L, Dutta S, Xiong S, Chan M, Chan KK, Fan TM, Bailey KL, Lindeblad M, Cooper LM, Rong L et\u2009al (2022) Engineered ACE2 decoy mitigates lung injury and death induced by SARS\u2010CoV\u20102 variants. Nat Chem Biol 18: 342\u2013351","journal-title":"Nat Chem Biol"},{"key":"BFEMMM202216109_CR71","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1164\/rccm.202001-0179LE","volume":"202","author":"Y Zhao","year":"2020","unstructured":"Zhao Y, Zhao Z, Wang Y, Zhou Y, Ma Y, Zuo W (2020) Single\u2010cell RNA expression profiling of ACE2, the receptor of SARS\u2010CoV\u20102. Am J Respir Crit Care Med 202: 756\u2013759","journal-title":"Am J Respir Crit Care Med"},{"key":"BFEMMM202216109_CR72","doi-asserted-by":"crossref","unstructured":"Zhou H, Tada T, Dcosta BM, Landau NR (2022) Neutralization of SARS\u2010CoV\u20102 omicron BA.2 by therapeutic monoclonal antibodies. bioRxivhttps:\/\/doi.org\/10.1101\/2022.02.15.480166 [PREPRINT]","DOI":"10.1101\/2022.02.15.480166"},{"key":"BFEMMM202216109_CR73","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1038\/s41591-020-0998-x","volume":"26","author":"SJ Zost","year":"2020","unstructured":"Zost SJ, Gilchuk P, Chen RE, Case JB, Reidy JX, Trivette A, Nargi RS, Sutton RE, Suryadevara N, Chen EC et\u2009al (2020) Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS\u2010CoV\u20102 spike protein. Nat Med 26: 1422\u20131427","journal-title":"Nat Med"},{"key":"BFEMMM202216109_CR74","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.1038\/ncomms4594","volume":"5","author":"Z Zou","year":"2014","unstructured":"Zou Z, Yan Y, Shu Y, Gao R, Sun Y, Li X, Ju X, Liang Z, Liu Q, Zhao Y et\u2009al (2014) Angiotensin\u2010converting enzyme 2 protects from lethal avian influenza a H5N1 infections. Nat Commun 5: 3594","journal-title":"Nat Commun"}],"container-title":["EMBO Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.15252\/emmm.202216109.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.15252\/emmm.202216109","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.15252\/emmm.202216109\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.embopress.org\/doi\/pdf\/10.15252\/emmm.202216109","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.15252\/emmm.202216109.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T06:46:04Z","timestamp":1779086764000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.15252\/emmm.202216109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,23]]},"references-count":74,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11,8]]}},"alternative-id":["BFEMMM202216109"],"URL":"https:\/\/doi.org\/10.15252\/emmm.202216109","relation":{},"ISSN":["1757-4676","1757-4684"],"issn-type":[{"value":"1757-4676","type":"print"},{"value":"1757-4684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,23]]},"assertion":[{"value":"31 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"EMMM202216109"}}